Stock listing

NASDAQ:ANTX AN2 Therapeutics, Inc. Stock

Home listing (NASDAQ) of AN2 Therapeutics, Inc.

Follow AN2 Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ANTX

$5.08 USD +0.13 (+2.6%)

Close on Nov 20, 2026

Past year +370.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.99 – $5.49 USDNov 20, 2026
Volume
332,710 sharesNov 20, 2026
Market cap
$192.8M USDAt the close on Nov 20, 2026 · price × 37.94M shares outstanding
52-week range
$1.00 – $7.19 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.33M USDMedian day 240,355 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
AN2 Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ANTX · Home$5.08 USD+0.13 (+2.6%)332,710$5.13$5.49$4.99$4.95Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ANTX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.08+0.13+2.6%$5.13$5.49$4.99332,710
$4.95+0.72+17.0%$4.40$5.32$4.23967,421
$4.23-0.24-5.4%$4.50$4.60$3.915285,651
$4.47-0.08-1.8%$4.51$4.70$4.365246,860
$4.55+0.11+2.5%$4.42$4.58$4.25205,686
$4.44-0.02-0.4%$4.48$4.75$4.34186,344
$4.46+0.13+3.0%$4.40$4.747$4.277197,630
$4.33+0.33+8.3%$3.99$4.505$3.93271,603
$4.000.000.0%$4.06$4.13$3.97496,679
$4.00+0.045+1.1%$3.99$4.11$3.90240,355
$3.955-0.295-6.9%$4.22$4.255$3.82152,967
$4.25+0.07+1.7%$4.22$4.31$4.10131,826
$4.18-0.17-3.9%$4.38$4.55$4.10160,400
$4.35-0.18-4.0%$4.54$4.64$4.241299,604
$4.53-0.16-3.4%$4.66$4.76$4.31284,722
$4.69+0.17+3.8%$4.57$4.90$4.53555,792
$4.52+0.66+17.1%$3.86$4.60$3.85545,417
$3.86+0.23+6.3%$3.61$3.89$3.54239,623
$3.63+0.08+2.3%$3.55$3.70$3.50196,183
$3.55-0.09-2.5%$3.61$3.66$3.47124,439
$3.64+0.04+1.1%$3.57$3.72$3.52195,191
$3.60+0.04+1.1%$3.58$3.78$3.57177,367
$3.56+0.19+5.6%$3.38$3.59$3.36129,744
$3.37-0.01-0.3%$3.39$3.46$3.21330,870
$3.38-0.22-6.1%$3.60$3.62$3.30281,730
$3.60+0.06+1.7%$3.50$3.69$3.50295,943
$3.54-0.06-1.7%$3.55$3.73$3.33431,025
$3.60-0.70-16.3%$4.30$4.32$3.59515,050
$4.30-0.10-2.3%$4.41$4.41$4.24298,465
$4.40-0.28-6.0%$4.65$4.67$4.26442,134
$4.68-0.17-3.5%$4.77$4.86$4.43427,826
$4.85-0.22-4.3%$5.02$5.06$4.695365,253
$5.07-0.54-9.6%$5.39$5.60$5.005318,215
$5.61-0.10-1.8%$5.69$5.86$5.50299,949
$5.71+0.09+1.6%$5.64$5.99$5.51451,333
$5.62+0.30+5.6%$5.29$5.73$5.155509,439
$5.32+0.23+4.5%$5.07$5.35$5.00199,204
$5.09+0.08+1.6%$4.99$5.20$4.76178,839
$5.01+0.13+2.7%$4.89$5.17$4.67318,456
$4.88-0.01-0.2%$4.91$4.95$4.71155,127
$4.89+0.06+1.2%$4.77$5.06$4.72258,937
$4.830.000.0%$4.86$4.95$4.67306,158
$4.83-0.13-2.6%$5.00$5.05$4.70191,680
$4.96-0.09-1.8%$5.06$5.25$4.92305,221
$5.05+0.15+3.1%$4.89$5.15$4.80670,954
$4.90-0.44-8.2%$5.39$5.47$4.88204,494
$5.34-0.02-0.4%$5.38$5.44$5.295146,046
$5.36-0.10-1.8%$5.43$5.50$5.20156,797
$5.46+0.05+0.9%$5.43$5.645$5.34221,486
$5.41-0.28-4.9%$5.70$5.78$5.40103,538
$5.69-0.04-0.7%$5.56$5.88$5.54222,312
$5.73-0.25-4.2%$5.98$6.125$5.605175,804
$5.98+0.09+1.5%$6.00$6.06$5.76335,287
$5.89-0.06-1.0%$5.97$6.06$5.8577,182
$5.950.000.0%$6.05$6.20$5.79199,660
$5.95+0.47+8.6%$5.46$6.00$5.46353,561
$5.48-0.07-1.3%$5.53$5.67$5.40215,423
$5.55-0.03-0.5%$5.58$5.645$5.40124,021
$5.58-0.16-2.8%$5.67$5.78$5.40240,866
$5.74+0.21+3.8%$5.46$5.79$5.46204,041
$5.53-0.13-2.3%$5.66$5.85$5.50287,524
$5.66+0.03+0.5%$5.67$5.80$5.60217,706
$5.63-0.18-3.1%$5.82$5.82$5.59171,420
$5.81+0.02+0.3%$5.84$5.89$5.50225,449
$5.79-0.17-2.9%$5.98$6.13$5.72195,335
Ticker
NASDAQ:ANTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All AN2 Therapeutics, Inc. news

Decks

AN2 Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
23 in the last 12 months · 62 in all · newest Nov 20, 2026 · oldest 2022
Decks
3 decks · latest September 2026

Where AN2 Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ANTX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ANTXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about AN2 Therapeutics, Inc.